rs61741688
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001272071.2(AP1S2):āc.288T>Cā(p.Ser96=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00291 in 1,190,496 control chromosomes in the GnomAD database, including 50 homozygotes. There are 915 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001272071.2 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP1S2 | NM_001272071.2 | c.288T>C | p.Ser96= | splice_region_variant, synonymous_variant | 3/6 | ENST00000672987.1 | NP_001259000.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP1S2 | ENST00000672987.1 | c.288T>C | p.Ser96= | splice_region_variant, synonymous_variant | 3/6 | NM_001272071.2 | ENSP00000500695 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0139 AC: 1554AN: 111916Hom.: 22 Cov.: 23 AF XY: 0.0122 AC XY: 417AN XY: 34100
GnomAD3 exomes AF: 0.00417 AC: 764AN: 183227Hom.: 9 AF XY: 0.00277 AC XY: 188AN XY: 67791
GnomAD4 exome AF: 0.00177 AC: 1907AN: 1078531Hom.: 28 Cov.: 27 AF XY: 0.00143 AC XY: 495AN XY: 346333
GnomAD4 genome AF: 0.0139 AC: 1555AN: 111965Hom.: 22 Cov.: 23 AF XY: 0.0123 AC XY: 420AN XY: 34159
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Aug 15, 2017 | - - |
not specified Benign:1
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 25, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at